Cooperative Groups Advised To Plan For Future Of Less Funding from NCI
In Brief: General Motors Cancer Research Foundation Prizewinners: Brock, Li, Fraumeni, Harlow
ODAC Recommends Ethyol, DaunoXome For FDA Approval
ORI Clears Los Angeles Physician Of Misconduct In NSABP Participation
Cancer Panel Urges Improved Funding For Basic Science
FDA, NIH Streamline Approvals For Gene Therapy Studies
Report Criticizes NIH Grant Review
NIH Policy On Diversity In Sponsored Meetings
Trending Stories
- An opportunity for Trump: Position U.S. cancer science to lead the world
- Former Maryland Governor Larry Hogan to receive Public Service Leadership Award from National Coalition for Cancer Survivorship
- The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear” - Grilled by Congress, Kennedy defends NIH and NCI budget cuts, freezes, and RIFs
To avoid “offending” pharma, NCI doesn’t study the causes of early-onset colon cancer, HHS secretary incorrectly alleges - NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - Kennedy’s claims notwithstanding, NCI clinical trials are delayed, enrollments reduced
NCI’s Steven A. Rosenberg: “Almost all patients are getting delayed by about a month, but then again, we’re turning away more patients.”
